Chugai Pharmaceutical Co. (CHGCY)
(Delayed Data from OTC)
$24.89 USD
+0.09 (0.36%)
Updated Aug 6, 2025 09:30 AM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Chugai Pharmaceutical Co., Ltd. Unsponsored ADR has a market cap of $81.62B, which represents its share price of $24.80 multiplied by its outstanding shares number of 3.29B. As a large-cap company, CHGCY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CHGCY 24.89 +0.09(0.36%)
Will CHGCY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CHGCY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHGCY
Are Medical Stocks Lagging AngioDynamics (ANGO) This Year?
Chugai Pharmaceutical Co. (CHGCY) Upgraded to Buy: Here's Why
CHGCY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
Other News for CHGCY
Chugai Pharmaceutical reports Q2 results
Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript
Harding Loevner Global Equity Q2 2025 Report
Chugai Pharmaceutical, Gero enter joint research, license agreement